Diagnostics News and Research

RSS

FASgen announces new diagnostic test for steatohepititis

FASgen Inc. announced it has successfully expanded the potential use for its serum FAS (fatty acid synthase) ELISA diagnostic research test, FAS-Detect ELISA for the identification of Non-Alcoholic Steatophepititis (NASH).

1 Jun 2007

Diagnostic tests for Malaria are often underused in Zambia

Despite improvements in the ability to diagnose malaria, these diagnostic tests are often underused in Zambia, and patients with negative test results are often prescribed anti-malaria medications, according to a study in the May 23/30 issue of JAMA , a theme issue on malaria.

24 May 2007

Evaluation of leading combination regimens for treating malaria

Ugandan children who received the combination therapy of artemether-lumefantrine experienced a lower rate of treatment failure compared to other combination therapies, according to a study in the May 23/30 issue of JAMA , a theme issue on malaria.

24 May 2007

Radically different approach to nuclear magnetic resonance

Detecting the molecular structure of a tiny protein using nuclear magnetic resonance (NMR) currently requires two things: a million-dollar machine the size of a massive SUV, and a large sample of the protein under study.

16 May 2007

Predicting the next pandemic

In planning for a future influenza pandemic, most experts agree that two things are known for certain, there will be another pandemic someday, and nobody can predict when.

9 May 2007

Lab-on-a-chip speeds proteomics research

In recent years, the science of biology has been dominated by genomics, the study of genes and their functions.

4 May 2007

Biomarker discovery bodes well for better cancer diagnostics

While new findings from Ohio State University scientists suggest a genetic marker that could help distinguish between chronic pancreatitis and pancreatic cancer and gauge who will do well with cancer treatment, a pharmacologist at the Kimmel Cancer Center at Jefferson in Philadelphia sees the discovery as much more.

2 May 2007

3M and Gen-Probe collaborate to combat healthcare-associated infections

3M and Gen-Probe have announced that the companies have formed an exclusive worldwide collaboration to develop and commercialize rapid, easy-to-use nucleic acid tests to detect certain dangerous healthcare-associated infections (HCAIs) such as methicillin-resistant Staphylococcus aureus (MRSA).

1 May 2007

New searchable influenza gene database

A Medical College of Wisconsin and Children's Research Institute team in Milwaukee has created a free, searchable genetic database that will significantly improve diagnostic testing and genetic tracking of human and animal influenza viruses.

26 Apr 2007

Relationship found between DNA nanomechanics and damage

It has long been known that UV light can damage DNA, reducing its ability to replicate and interact with proteins, and often resulting in the development of skin cancers.

25 Apr 2007

Luminex Corporation licenses cystic fibrosis gene patent from John Hopkins

Luminex Corporation has announced that it has acquired a non-exclusive license from The Johns Hopkins University for the rights to use the university's patented cystic fibrosis genetic markers in the company's molecular diagnostic products sold in the United States.

From Luminex 25 Apr 2007

Gold nanoparticles for early detection of cancer

By attaching gold nanoparticles - like tiny balls or rods- to cancer cells, earlier detection will be possible.

24 Apr 2007

Enigma Diagnostics appoints Dr Lynn Busteed as CEO

Enigma Diagnostics has announced the appointment of Dr Lynn Busteed as Chief Executive Officer (CEO) and a member of the Board of Directors.

24 Apr 2007

Study evaluates CaP risk among finasteride users

Current medical management for BPH includes alpha-blockers and 5- reductase inhibitors.

20 Apr 2007

New automated test for gene mutations causing fragile X syndrome

A new automated test could enable population screening to identify carriers of the gene mutations causing fragile X syndrome (FXS), the most common inherited form of mental retardation, reports a study in the April issue of Genetics in Medicine, published by the American College of Medical Genetics and Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

19 Apr 2007

Towards universal access: scaling up priority HIV/AIDS interventions in the health sector

Access to antiretroviral therapy for advanced HIV infection in low- and middle-income countries continued to grow throughout 2006, with more than 2 million people living with HIV/AIDS receiving treatment in December 2006, a 54% increase over the 1.3 million people on treatment one year earlier in these countries.

18 Apr 2007

Abbott and signs contract with Premier for diagnostic tests

Abbott has announced that it has signed a new group purchasing agreement with Premier, Inc., a leading healthcare alliance, for a broad line of the company's diagnostic products.

17 Apr 2007

Should stocks of smallpox virus be destroyed?

Smallpox was eradicated in 1980, but the virus still exists in WHO controlled depositories. In this week's BMJ , two experts go head to head over whether these stocks should be destroyed.

15 Apr 2007

A report for the ten year strategy for the reduction of vitamin and mineral deficiencies

A new report by AED Center for Nutrition and the Global Alliance for Improved Nutrition (GAIN) for the Food and Nutrition Bulletin shows that while cost-effective interventions to reduce vitamin and mineral deficiencies have existed for more than 20 years, significant micronutrient deficiencies still plague many countries, increasing maternal and child mortality and slowing brain development in children.

15 Apr 2007

Avista Capital acquires BioReliance from Invitrogen

Avista Capital Partners has announced it has completed its acquisition of BioReliance Corporation, a business unit of Invitrogen Corporation for approximately $210 million.

15 Apr 2007